了解美国成年人中COVID-19提振剂吸收率较低的情况
Elizabeth T Jacobs1, Felina M Cordova-Marks1, Leslie V Farland1
1Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, United States.
Vaccine
|September 4, 2023
概括
许多美国人由于先前的感染或对安全性和有效性的担忧而没有获得更新的COVID-19助推剂. 了解这些原因对于改善疫苗接种率和公共卫生战略至关重要.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 虽然COVID-19疫苗可以减轻严重的疾病,但在美国,双价增强剂的吸收率很低 (<20%).
- 了解促进吸收的障碍对于公共卫生倡议至关重要.
研究的目的:
- 识别和分析个人没有接收双价COVID-19助推剂的原因.
- 评估人口统计学关联与未接受双价增强剂的具体原因.
主要方法:
- 在亚利桑那州CovHORT队列中对2196名成年参与者进行调查.
- 收集关于收到双价增强剂的数据以及未收到的原因.
- 描述性统计和多变量后勤回归分析了参与者的特征和不接种疫苗的原因.
主要成果:
- 之前的SARS-CoV-2感染 (39.5%) 是不接受提升的最常见原因.
- 担心疫苗副作用 (31.5%),缺乏额外保护 (28.6%) 和安全问题 (23.4%) 也是重要的障碍.
- 老年人对知识或后勤问题不太担心,而西班牙裔个人则报告了更多的后勤问题. 那些有一些大学教育的人更有可能引用不清楚的风险和好处.
结论:
- 低双价增强剂吸收在美国是一个公共卫生挑战.
- 要提高疫苗接种率,需要针对特定问题 (例如安全性,有效性,物流,信息明确性) 的有针对性的干预措施.
- 开发和实施有效的策略来增加增强剂的吸收对于持续的流行病管理至关重要.
相关概念视频
Vaccinations
44.7K
Overview
44.7K
Bias in Epidemiological Studies
349
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
349
Confounding in Epidemiological Studies
188
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
188
Prevalence and Incidence
623
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
623
Dose-Response Relationship: Potency and Efficacy
4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
Confidence Interval for Estimating Population Mean
7.6K
A point estimate of the population mean is obtained from a single sample. Such a point estimate does not represent a population well because it needs to account for variability in the population. Single point estimate can also be biased despite the sample being selected randomly. Thus, a point estimate is often unreliable. A confidence interval is needed to reduce this unreliability.
A confidence interval for the mean is a range of values that provides an estimate of the population mean. As the...
A confidence interval for the mean is a range of values that provides an estimate of the population mean. As the...
7.6K


